Notably, BT5 also impaired the clonogenic growth of primary NUP98-NSD1+ AML cells but not leukemic cells carrying an KMT2A-MLLT1 fusion or normal human CD34+ hematopoietic stem and progenitor cells. Here, NSD1 is linked to acute myeloid leukemia.